Exam 2 - Hypercalcemia/SREs Flashcards

1
Q

In which type of cancer is HCM the most common?

A

lung cancer (35%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

S/Sx of moderate-severe hypercalcemia

A

lethargy and confusion
seizures
arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

corrected calcium =

A

serum Ca + 0.8 (4 - serum albumin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

severe hypercalcemia: Ca > ______ mg/dL

A

14

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Moderate hypercalcemia treatment options

A

Hydration - will work quicker than Bisphosphonates
Bisphosphonates - zoledronic acid 4mg IV over 15mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Severe hypercalcemia treatment options

A

HYDRATION!! (usually 200mL/hr)
Bisphosphonates
Calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What drug may be used for treatment refractory HCM?

A

Denosumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which agents are used for chronic HCM?

A

Bisphosphonates:
Zoledronic acid
Pamidronate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which cancer patient populations are at higher risk for fracture?

A
  1. women with breast cancer -> especially on aromatase inhibitors, low BMI, history of fracture, smoker
  2. men with prostate cancer -> on ADT, smoker
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment options for bone metastases

A
  1. radiation (85% response rate)
  2. chemotherapy
  3. IV bone modifying agents: bisphosphonates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IV bisphosphonates (zoledronic acid and pamidronate) require ______ _______ ___________ when used for skeletal related events

A

renal dose adjustments

**not required when used for hypercalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bisphosphonates should be supplemented with…..

A

calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pamidronate has a __________ infusion time than zoledronic acid

A

longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does denosumab require renal dose adjustments?

A

NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which formulation of denosumab is used for bone metastases from solid tumors?

A

Xgeva 120mg SQ every 4 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which formulation of denosumab is used for women at high risk of fracture or using an aromatase inhibitor or for men receiving ADT?

A

Prolia 60mg SQ every 6 months

17
Q

What are some adverse effects of bone-modifying therapies?

A
  1. Osteonecrosis (zoledronic, denosumab)
  2. Hypocalcemia (denosumab)